Due to its role in myelin sheath production, it's the preferred form for women with nerve or spinal cord problems
Details are provided in the Table 1
Injection burden 1-2 injections per day on overlap days Best for Metabolic + mitochondrial pairing Cycle driver Retatrutide titration sets the pace Retatrutide Loading 1 2 4 6 9 mg (every 4 weeks) Frequency Once weekly Maintenance 9 mg or 12 mg weekly Route SubQ MOTS-c (intermittent - most common) Loading Start Week 5: 5 mg, 2x weekly Frequency 2-3x weekly Maintenance 5-10 mg, 2-3x weekly Route SubQ MOTS-c (low-dose daily - alternative) Loading Start Week 5: 200 mcg/day, +200 mcg every 2 weeks Frequency Daily Maintenance Up to 1 mg daily Route SubQ Weekly Schedule Example - Intermittent MOTS-c (Weeks 5-16) Monday Retatrutide 2 mg (morning) + MOTS-c 5 mg (pre-training) Tuesday Rest day Wednesday MOTS-c 5 mg (pre-training) Thursday Rest day Friday MOTS-c 5 mg (pre-training) Saturday Rest day Sunday Rest day Community protocols use different injection sites and separate syringes when both compounds are dosed the same day

How Its Administered Taken orally as a standard capsule or tablet Doses typically range from 2501,000 mcg per serving, often once or twice daily No mixing or refrigeration required Pros Convenient and needle-free Travel-friendly and easy to store Familiar supplement format (great for compliance) May offer limited GI tract effects if it survives digestion Cons Very low bioavailability due to breakdown in stomach acid No clinical research validating capsule efficacy May contain unverified peptide content or underdosed formulas Often marketed as dietary supplements, not research-grade peptides Best For Casual users seeking convenience or placebo-based support Individuals with mild digestive discomfort looking for a general gut health product Users who cannot access injectable or oral liquid BPC157, but still want to try the compound If considering capsules, look for third-party testing and clear labeling of dosage and peptide identity many products on the market may not contain actual BPC157

Selenite-induced cataracts are primarily driven by oxidative stress, as evidenced by elevated malondialdehyde (MDA) levels and reduced antioxidant enzyme activities, including catalase (CAT) and glutathione (GSH)
In this way, two toxic species, superoxide radical and hydrogen peroxide, are converted to the harmless product water